Dr. F. Köhler Chemie GmbH   Report issue

For profit Phase 3
Founded: Bensheim Germany (1959)

Organization Overview

First Clinical Trial
2018
NCT03627013
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Dr. F. Köhler Chemie GmbH

Active Ingredients

Drugs in Phase 3 Trials (1)

crystalloid (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

End Stage Liver Disease (Phase 3)

Liver Failure (Phase 3)

Renal Insufficiency (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1